Search results
Very good news for Geron stock price: now what? | Invezz
Invezz· 4 days agoGeron Corporation (NASDAQ: GERN) stock price went vertical on Friday as investors cheered the latest...
Analog Devices CEO Vincent Roche sells $2.35 million in stock By Investing.com
Investing.com· 6 days agoThe sale was executed under a 10b5-1 trading plan, which was adopted by Roche on March 1, 2024. In...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 6 days agoWe believe all these factors should keep the stock afloat this year. Zacks Rank Teva currently has a...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoIn the first quarter, Halozyme earned an adjusted 79 cents per share on $196 million in sales, up a...
Amid surging tech stocks and salaries, HubSpot CEO doubled her pay to $26 million last year - The...
The Boston Globe· 6 days agoAfter a strong year for technology stock returns, tech company leaders around Boston saw their total...
The Best Everyday Office Perfume for Men
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we will talk about the Best Everyday Office Perfume for Men. For our detailed discussion, go directly to the 15 Best Everyday Office...
Inari's Expanding Product Portfolio Offsets Competition - Boston Scientific (NYSE:BSX), Align Tech...
Benzinga· 6 days agoInari Medical NARI continues to ride on the success of its ClotTriever and FlowTriever products...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 4 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside - Regenxbio...
Benzinga· 3 days agoGoldman Sachs initiates coverage on RGNX, citing potential of gene therapy platform.
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study
Zacks via Yahoo Finance· 6 days agoAffimed (AFMD) rallies 69% on positive follow-up efficacy data from its early to mid-stage study of...